Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: A meta-analysis of
Atsuhiro Sakamoto1, Toshimitsu Hamasaki, Masafumi Kitakaze
1Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School, Tokyo, 113-8603, Japan, no1-saka@nms.ac.jp.
Insights
Perioperative landiolol significantly reduces the incidence of postoperative atrial fibrillation (POAF) after cardiac surgery. This ultra-short acting beta-blocker is well-tolerated and effective in preventing POAF in various patient groups.
Area of Science:
- Cardiology
- Pharmacology
- Surgical Complications
Background:
- Postoperative atrial fibrillation (POAF) is a frequent complication following cardiac surgery.
- POAF is associated with extended hospital stays and increased stroke risk.
- Beta-blockers are recommended for POAF prevention and treatment.
Purpose of the Study:
- To evaluate the effectiveness of landiolol for preventing POAF after cardiac surgery.
- To assess the safety of landiolol administration in this patient population.
Main Methods:
- A meta-analysis of randomized controlled trials (RCTs) was conducted.
- Studies compared perioperative landiolol with control groups (saline, no drug, or other treatments).
- Data on POAF incidence and safety outcomes were extracted and analyzed using a fixed-effects model.
Main Results:
- Six trials involving 560 patients were included.
- Landiolol significantly reduced POAF incidence (OR 0.26, 95% CI 0.17-0.40).
- Effectiveness was consistent across coronary artery bypass grafting (CABG) and general cardiac surgery patients, and against saline/no treatment controls. Adverse events were rare (0.7%).
Conclusions:
- Landiolol administration effectively reduces POAF incidence post-cardiac surgery.
- Landiolol is well-tolerated in patients undergoing cardiac procedures.
Introduction:
Postoperative atrial fibrillation (POAF) is one of the most common complications after cardiac surgery. Patients who develop POAF have a prolonged stay in the intensive care unit and hospital and an increased risk of postoperative stroke. Many guidelines for the management of cardiac surgery patients, therefore, recommend perioperative administration of beta-blockers to prevent and treat POAF. Landiolol is an ultra-short acting beta-blocker, and some randomized controlled trials of landiolol administration for the prevention of POAF have been conducted in Japan. This meta-analysis evaluated the effectiveness of landiolol administration for the prevention of POAF after cardiac surgery.
Methods:
The Medline/PubMed and BioMed Central databases were searched for randomized controlled trials comparing cardiac surgery patients who received perioperative landiolol with a control group (saline administration, no drug administration, or other treatment). Two independent reviewers selected the studies for inclusion. Data regarding POAF and safety outcomes were extracted. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using the Mantel-Haenszel method (fixed effects model).
Results:
Six trials with a total of 560 patients were included in the meta-analysis. Landiolol administration significantly reduced the incidence of POAF after cardiac surgery (OR 0.26, 95% CI 0.17-0.40). The effectiveness of landiolol administration was similar in three groups: all patients who underwent coronary artery bypass grafting (CABG) (OR 0.27, 95% CI 0.17-0.43), patients who underwent CABG compared with a control group who received saline or nothing (OR 0.28, 95% CI 0.17-0.45), and all patients who underwent cardiac surgery compared with a control group who received saline or nothing (OR 0.27, 95% CI 0.17-0.42). Only two adverse events associated with landiolol administration were observed (2/302, 0.7%): hypotension in one patient and asthma in one patient.
Conclusion:
Landiolol administration reduces the incidence of POAF after cardiac surgery and is well tolerated.
More Related Videos
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Statistical Software for Data Analysis and Clinical Trials
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Trial and Error and Algorithm
Clinical Trials: Overview